Innovations in repetitive transcranial magnetic stimulation: a review of clinical evidence and patient-reported outcomes for ExoTMS.
93.3% of ExoTMS patients reported treatment as comfortable with minimal to no pain
Innovations in repetitive transcranial magnetic stimulation: a review of clinical evidence and patient-reported outcomes for ExoTMS.
Transcranial magnetic stimulation (transcranial magnetic stimulation) is a non-invasive neuromodulation technique with demonstrated efficacy in the treatment of multiple psychiatric and neurological disorders.
This review examines the technological characteristics, safety profile, and therapeutic implications of ExoTMS, with particular attention to patient-reported outcomes, treatment comfort, and safety.
Eight studies were included, comprising 182 active-treated participants who received stimulation at effective intensity levels.
Patients reported high satisfaction with ExoTMS treatment, with improvements observed immediately post-treatment, and further increases at follow-up.
Improvements were noted across multiple domains, including overall well-being, mood, perceived stress, and mental energy.
No serious adverse events were reported.
ExoTMS appears to be a well-tolerated transcranial magnetic stimulation-based intervention characterized by favorable treatment comfort, minimal pain, and the absence of serious adverse events.
Patient-reported outcomes suggest improvements in well-being and self-regulatory domains that persist beyond the immediate treatment period.
Compared with conventional transcranial magnetic stimulation systems, ExoTMS may offer practical advantages, including reduced treatment burden and improved clinical workflow efficiency.